Lewis Lanier

42PUBLICATIONS
157CO-AUTHORS
Micro- and nanosystemsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cardiology (incl. cardiovascular diseases)Genetic immunologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (42)

|Nov 24, 2025
Site-specific genome engineering of primary human natural killer cells for programmable anti-tumor function.

Vincent Allain, Allison G Rothrock, Pierre-Louis Bernard

|Mar 12, 2025
SYK negatively regulates ITAM-mediated human NK cell signaling and CD19-CAR NK cell efficacy.

Alberto J Millan, Vincent Allain, Indrani Nayak

|Feb 13, 2025
CITE-Seq Analysis Reveals a Differential Natural Killer Cell SPON2 Expression in Cardiovascular Disease Patients Impacted by Human-Cytomegalovirus Serostatus and Diabetes.

Sujit Silas Armstrong, Daniel G Chen, Sunil Kumar

|Jul 19, 2024
Spleen Tyrosine Kinase (SYK) negatively regulates ITAM-mediated human NK cell signaling and CD19-CAR NK cell efficacy.

Alberto J Millan, Vincent Allain, Indrani Nayak

|Jul 02, 2024
High-dimensional single-cell analysis of human natural killer cell heterogeneity.

Lucas Rebuffet, Janine E Melsen, Bertrand Escalière

|Jun 06, 2024
Five decades of natural killer cell discovery.

Lewis L Lanier

Pageof 7

Frequent Collaborators

9 joint publications

Oscar A Aguilar

6 joint publications

Avishai Shemesh

4 joint publications

Sonja Schrepfer

3 joint publications

Alberto Millan